Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1949 1
1965 3
1966 3
1968 1
1970 1
1971 1
1972 1
1973 3
1975 1
1976 3
1977 3
1978 2
1979 2
1980 4
1981 2
1982 2
1983 5
1984 1
1985 3
1986 4
1987 6
1988 2
1989 4
1990 4
1991 5
1992 6
1993 2
1994 8
1995 4
1996 6
1997 10
1998 5
1999 4
2000 8
2001 4
2002 8
2003 8
2004 5
2005 6
2006 4
2007 2
2008 2
2009 3
2010 4
2011 5
2012 4
2013 4
2014 8
2015 5
2016 4
2017 5
2018 7
2019 8
2020 10
2021 6
2022 9
2023 12
2024 9
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

252 results

Results by year

Filters applied: . Clear all
Page 1
Future Directions in the Treatment of Osteosarcoma.
Smrke A, Anderson PM, Gulia A, Gennatas S, Huang PH, Jones RL. Smrke A, et al. Among authors: anderson pm. Cells. 2021 Jan 15;10(1):172. doi: 10.3390/cells10010172. Cells. 2021. PMID: 33467756 Free PMC article. Review.
Immune Therapy for Sarcomas.
Anderson PM. Anderson PM. Adv Exp Med Biol. 2017;995:127-140. doi: 10.1007/978-3-319-53156-4_6. Adv Exp Med Biol. 2017. PMID: 28321815 Review.
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.
Meyers PA, Federman N, Daw N, Anderson PM, Davis LE, Kim A, Macy ME, Pietrofeso A, Ratan R, Riedel RF, Trucco M, Breitmeyer JB, Toretsky JA, Ludwig JA. Meyers PA, et al. Among authors: anderson pm. J Clin Oncol. 2024 Nov;42(31):3725-3734. doi: 10.1200/JCO.24.00020. Epub 2024 Jul 2. J Clin Oncol. 2024. PMID: 38954782 Clinical Trial.
Tilsotolimod Exploits the TLR9 Pathway to Promote Antigen Presentation and Type 1 IFN Signaling in Solid Tumors: A Multicenter International Phase I/II Trial (ILLUMINATE-101).
Babiker H, Borazanci E, Subbiah V, Agarwala S, Algazi A, Schachter J, Lotem M, Maurice-Dror C, Hendler D, Rahimian S, Minderman H, Haymaker C, Mahadevan D, Bernatchez C, Murthy R, Hultsch R, Kaplan N, Woodhead G, Hennemeyer C, Chunduru S, Anderson PM, Diab A, Puzanov I. Babiker H, et al. Among authors: anderson pm. Clin Cancer Res. 2022 Dec 1;28(23):5079-5087. doi: 10.1158/1078-0432.CCR-21-4486. Clin Cancer Res. 2022. PMID: 35917516 Free PMC article.
252 results